title: Managing invasive fungal disease in immunocompromised patients.
abstract: Celebrating its 30th anniversary in Budapest this year, the International Immunocompromised Host Society (ICHS) was established to advance the understanding of interactions between host defenses and microbial agents in order to improve the prevention and management of human disease in patients with compromised immune function. Much has been achieved in the intervening years, and presentations on the challenges of invasive fungal disease at this year's ICHS congress reflected the changing nature of the population at risk of fungal disease, the growing range of fungal pathogens, and evolving approaches to the prevention, diagnosis and treatment of fungal infection.
authors.affiliation: Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium. johan.maertens@uz.kuleuven.ac.be
authors.forename: Johan
authors.initials: J
authors.lastname: Maertens
authors.forename: Jenny
authors.initials: J
authors.lastname: Bryan
mesh_terms: D019072:Antibiotic Prophylaxis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016867:Immunocompromised Host; D007167:Immunotherapy; D055552:Infectious Disease Medicine; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control* / Q000628:therapy; D012307:Risk Factors; D016879:Salvage Therapy; D014195:Travel; D014230:Triazoles / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole